Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
The latest update is out from Angelalign Technology Inc. ( (HK:6699) ).
Angelalign Technology Inc. has disclosed the current composition of its board of directors, detailing a mix of executive and independent non-executive directors and formalising their respective roles. The move clarifies the company’s governance structure following recent changes and signals an emphasis on defined leadership responsibilities across core management functions.
The board has also confirmed the membership and chairmanship of its Audit, Remuneration, and Nomination Committees, allocating oversight duties among its independent non-executive directors. This committee configuration underscores Angelalign’s focus on regulatory compliance, transparent financial reporting, and structured oversight of executive pay and director appointments, which are key concerns for investors and other stakeholders.
The most recent analyst rating on (HK:6699) stock is a Buy with a HK$91.89 price target. To see the full list of analyst forecasts on Angelalign Technology Inc. stock, see the HK:6699 Stock Forecast page.
More about Angelalign Technology Inc.
Angelalign Technology Inc., incorporated in the Cayman Islands and listed in Hong Kong under stock code 6699, operates in the medical technology sector with a focus on orthodontic solutions. The company is led by an executive team that includes a chairman, a chief executive officer who also serves as chief technology officer, a president for global business outside mainland China, and a chief financial officer.
Average Trading Volume: 824,490
Technical Sentiment Signal: Buy
Current Market Cap: HK$15.24B
For an in-depth examination of 6699 stock, go to TipRanks’ Overview page.

